Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 4.600
0.00 (0.00%)
May 7, 2026, 4:08 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 1.67 billion as of May 7, 2026. Its market cap has increased by 25.22% in one year.
Market Cap
1.67B
Enterprise Value
1.15B
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.60
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 1.67B, a decrease of -74.95%. That is a compound annual growth rate of -37.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.67B | 1.32% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 2.59B |
| Frontage Holdings | 1.99B |
| SinoMab BioScience | 1.98B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Mabpharm | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.72B |
| Beijing Biostar Pharmaceuticals | 1.71B |
| Zhaoke Ophthalmology | 1.62B |